Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03240510

Enrollment

150

Registered

2017-08-07

Start date

2014-01-01

Completion date

2018-01-01

Last updated

2017-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Breast Cancer

Keywords

Breast cancer, Male

Brief summary

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinicopathologic data and follow-up outcomes of male breast cancer patients diagnosed and/or treated at Salah Azaïz Cancer Institute from 2004 to 2013. Goal of the prospective part: to create a registry of male patients with breast cancer for a period of 48 months (from 2014 to 2017).

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Histological diagnosis of male breast cancer

Design outcomes

Primary

Measure	Time frame	Description
Clinical outcomes	Through study completion, an average of 4 year	Survival, Disease free survival
Clinico-biological characteristics of the disease	Through study completion, an average of 4 year	—

Countries

Tunisia

Outcome results